News & Events – IP Group plc

Search in site

IP Group news

11 Feb 2026

Portfolio company Microbiotica announces impressive results in its Phase 1b trial of MB310 in Ulcerative Colitis

IP Group plc

14 Jan 2026

IP Group plc

07 Jan 2026

Portfolio company Pulmocide announces termination of Opera-T Phase 3 study with Opelconazole

IP Group plc

See all IP Group news

Portfolio news

16 Feb 2026

Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline

Artios Pharma

11 Feb 2026

Microbiotica announces impressive results in its Phase 1b trial of MB310 in Ulcerative Colitis

Microbiotica Ltd

05 Feb 2026

Quantum Motion Expands Global Presence by Opening European Offices in Spain

Quantum Motion Technologies

See all portfolio news

Events

September 2025

17

2025 Half Year Results Webinar

Virtual

Event has passed

June 2025

26

Capital Markets Day

45 Gresham Street, London

Event has passed

June 2025

12

AGM

Hybrid

Event has passed

Downloads and key links